Research Article
Correlation of Neuroimaging Findings with Clinical Presentation and Laboratory Data in Patients with COVID-19: A Single-Center Study
Table 2
Brain imaging results of 436 COVID-19 patients.
| Variable | Value |
| Brain CT () | | Time of first CT exam (days) | 7 (6-9) | No abnormality | 265 (62.7) | Infarction | 15 (3.5) | Intracranial hemorrhage | 8 (1.9) | Nonspecific white matter changes | 135 (31.9) | Brain MRI () | | Time of first MR exam (days) | 8 (6-10) | Intracranial hemorrhage (for SWI) | 10 (4.1) | Nonspecific white matter changes | 123 (50.6) | Location of nonspecific white matter changes () | | Frontal lobe | 78 (63.4) | Parietal lobe | 68 (55.3) | Temporal lobe | 32 (26.0) | Occipital lobe | 25 (20.3) | Pons-mesencephalon | 19 (15.4) | Basal ganglia | 32 (26.0) | Corpus callosum | 12 (9.8) | Periventricular | 41 (33.3) | Cerebellar | 7 (5.7) | CTA () | | Occlusion | 8 (44.4) | Right MCA | 5 (62.5) | Left MCA | 1 (12.5) | Left PCA | 2 (25.0) | MRA () | | Occlusion | 5 (45.5) | Right MCA | 3 (60.0) | Right PCA | 1 (20.0) | Venous sinus thrombosis | 1 (20.0) | DWI () | | Time of first diffusion exam (days) | 8 (6-10) | Infarction | 46 (28.2) | Infarction site | | Right hemisphere | 13 (28.3) | Left hemisphere | 12 (26.1) | Both hemisphere | 18 (39.1) | Cerebellum | 3 (6.5) |
|
|
Interval between diagnosis of COVID-19 and first brain imaging exam. |